Please select a video from the list below.
PAH-Related Morbidity Is Prognostic for Mortality
In this important breaking trial analysis publication, Dr. Vallerie McLaughlin discusses the use of landmark analysis procedures on morbidity and mortality endpoints from 2 large Phase 3 trials, SERAPHIN and GRIPHON. The publication, published in JACC shows how a clinical morbidity event influences risk of death in patients treated with or without macitentan or selexipag. Dr. McLaughlin discusses the importance of using these findings to adjust patients' therapeutic management.